Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Barbara Gitlitz
Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Vinorelbine and Gemcitabine as Second- Or Third-Line Therapy for Malignant Pleural Mesothelioma
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Enhanced Cisplatin Response With Histone Acetyl Transferase Inhibitor, Anacardic Acid, in Malignant Pleural Mesothelioma Cell Line
Turkiye Klinikleri Journal of Medical Sciences
Medicine
OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- Or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies
Molecular Cancer Therapeutics
Cancer Research
Oncology
Phase II Study of Cediranib in Patients With Malignant Pleural Mesothelioma: SWOG S0509
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) as Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Malignant Pleural Mesothelioma
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
